![]() |
Volumn 15, Issue 4, 2009, Pages 399-403
|
Randomized trial comparing locoregional resection of primary tumor with no surgery in stage iv breast cancer at the presentation (Protocol MF07-01): A study of turkish federation of the national societies for breast diseases
|
Author keywords
Breast cancer; Metastasis; Randomized trial; Surgery; Survival
|
Indexed keywords
DOCETAXEL;
DOXORUBICIN;
ESTROGEN RECEPTOR;
GONADORELIN DERIVATIVE;
PROGESTERONE RECEPTOR;
TAMOXIFEN;
TRASTUZUMAB;
ADULT;
AGED;
ARTICLE;
BREAST CANCER;
BREAST DISEASE;
CANCER CHEMOTHERAPY;
CANCER HORMONE THERAPY;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISTANT METASTASIS;
DRUG DOSE SEQUENCE;
FEMALE;
FOLLOW UP;
HUMAN;
KAPLAN MEIER METHOD;
LYMPH NODE METASTASIS;
MAJOR CLINICAL STUDY;
MASTECTOMY;
MEDICAL SOCIETY;
MORBIDITY;
MULTICENTER STUDY;
MULTIMODALITY CANCER THERAPY;
MULTIPLE CYCLE TREATMENT;
OVERALL SURVIVAL;
PHASE 3 CLINICAL TRIAL;
POSTMENOPAUSE;
PREMENOPAUSE;
PRIMARY TUMOR;
PROGRESSION FREE SURVIVAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
SHORT FORM 36;
TREATMENT OUTCOME;
TURKEY (REPUBLIC);
BREAST NEOPLASMS;
FEMALE;
HUMANS;
MASTECTOMY, SEGMENTAL;
NEOPLASM STAGING;
PROGNOSIS;
PROPORTIONAL HAZARDS MODELS;
SURVIVAL ANALYSIS;
SURVIVORS;
TIME FACTORS;
TREATMENT OUTCOME;
TURKEY;
|
EID: 67650760407
PISSN: 1075122X
EISSN: 15244741
Source Type: Journal
DOI: 10.1111/j.1524-4741.2009.00744.x Document Type: Article |
Times cited : (75)
|
References (14)
|